Braze (BRZE) Draws Goldman Backing, Is The Stock 39% Below Fair Value?

Braze

Braze

BRZE

0.00

Why Braze Stock Is Back On Investors’ Radar

Attention around Braze (BRZE) has picked up after Goldman Sachs began research coverage with a positive view. This development comes alongside friendlier conditions for SaaS valuations and broadly upbeat analyst sentiment toward the stock.

Despite Goldman’s upbeat coverage and a 7-day share price return of 8.88%, Braze is still down 18.18% on a 30-day share price basis and its 1-year total shareholder return is lower by 25.56%. As a result, recent momentum looks more like a short-term rebound than a clear trend shift.

If you are watching how sentiment around AI-focused software stocks develops, it can be useful to see what else is moving and compare quality across the space using our screener for 62 profitable AI stocks that aren't just burning cash

With Braze stock still down sharply over the past year, yet trading at a sizeable discount to analyst price targets, the key question for investors is whether this is a genuine opportunity or if the market already reflects future growth.

Most Popular Narrative: 39% Undervalued

The most followed valuation narrative for Braze points to a fair value of $34.40 per share, compared with a last close of $20.97. This frames the stock as materially discounted and puts the focus on whether the underlying assumptions hold up.

Braze's acquisition of OfferFit is expected to enhance AI-driven optimization capabilities and lead to revenue growth through deal size expansion and differentiation in the market. This investment should drive better earnings and net margins as OfferFit's sophisticated AI solutions integrate into Braze's platform.

Want to see what is behind that fair value for Braze? The narrative places particular weight on compound revenue growth, margin uplift, and a richer earnings base. The real story is in how those pieces fit together over time.

Result: Fair Value of $34.40 (UNDERVALUED)

However, investors in Braze also need to weigh execution risks around integrating OfferFit, as well as the potential impact of changing international data laws on costs and margins.

Next Steps

Given the mixed sentiment around Braze, with both risks and rewards on the table, it may be useful to move quickly and review the underlying data yourself so you can weigh the 3 key rewards and 2 important warning signs

Looking For More Investment Ideas Beyond Braze?

If Braze has caught your attention, do not stop there. Use the Simply Wall Street Screener to uncover other opportunities that fit your style before the crowd does.

  • Explore companies with strong finances and lower perceived risk profiles using the 72 resilient stocks with low risk scores.
  • Look for potentially attractive valuations by scanning the market for opportunities using the 42 high quality undervalued stocks.
  • Review income-generating companies that pay dividends with the 9 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.